Abstract:OBJECTIVE To analyze the expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors and their relationship with clinical pathological features. METHODS The expressions of Ki67, PCNA protein and mitotic index in ovarian tissues from 20 patients with normal ovarian tissues, 28 patients with ovarian benign tumors, 20 patients with borderline tumors and 109 (73 metastatic ovarian cancer) patients with malignant tumors were retrospectively tested using the American GBI immunohistochemistry two-step method. The expressions of Ki67 and PCNA mRNA were also detected by in situ hybridization (ISH) in ovarian tissues from 37 patients with primary ovarian cancer, 14 patients with borderline tumors, 11 patients with benign tumors and 12 patients with normal ovarian tissues. The relationship between clinical pathologic parameters and the expressions of Ki67 and, PCNA and mitotic index in human ovarian tumors was analyzed. RESULTS (1) The expressions of Ki67 mRNA and protein in ovarian epithelial tumors was higher than in the controls (P = 0.003; P = 0.009; P = 0.001; P = 0.001). But no significant differences appeared in the expression and overexpression of PCNA mRNA and pratein (P = 0.327; P = 0.718; P = 0.123; P = 0.125). Positive correlations between the expressions of mRNA and protein for Ki67 and PCNA were found (r = 0.449, P = 0.025; r = 0.484, P = 0. 014). (2) The expression of Ki67 in ovarian epithelial was higher in low differential carcinoma and at FIGO III-IV stage (P = 0.008; P = 0.007). The expression of Ki67 protein in serous tumor tissues was high, but low or missed in other types of tumor tissues such as malignant mixed mullerian tumor and transitional cell carcinoma (P = 0. 018). No significant differences in other clinicopathological features were found. The high expression of PCNA did not coincide with histological grading, clinical stage and histological types (P = 0.447; P = 0.763; P = 0.657). There were 72 patients with high mitotic index (66.1%). The high expression of mitotic index coincided with histological grading and clinical stage, but not with histological types (P = 0.002; P = 0.040). (3) The combined overexpression of Ki67 and high mitotic index occurred in 57 patients, which coincided with histological grading, clinical stage and histological types (P = 0.018; P = 0.001; P = 0.020). (4) In the 73 patients with metastatic ovarian cancers, the expressions of Ki67 (58.9%), PCNA protein (91.8%) and high MI (61.6%) in primary cancer tissues were greater than in the metastatic cancer tissues (peritoneum and epiploon, Ki67 41.4%, P = 0.031; PCNA 74%, P = 0.004; high MI 38.4%, P = 0.005). The positive intensity of Ki67 protein expression in primary ovarian cancers was significantly higher than in metastatic ovarian cancers (P = 0.040). There was no significant difference in positive intensity of PCNA between primary and metastatic ovarian cancers (P = 0.514). CONCLUSION Ki67 and mitotic index can serve as biomolecular markers for predicting the proliferation of malignant ovarian epithelial tumors. PCNA can not discriminate between benign and malinant ovarian tumors.

Relationship between multidirectional differentiation of malignant ovarian epithelial tumors and Ki67 expression

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.

[Preliminary Study of Neuroendocrine Differentiation and Its Mechanism in Ovarian Epithelial Tumors].

[Expressions of Ki67, PCNA and Mitotic Index in Ovarian Epithelial Tumors].

Clinical Significance and Prognostic Value of Extracellular Signal-Regulated Kinases in Epithelial Ovarian Cancer

[Tumor-Infiltrating Dendritic Cells in Epithelial Ovarian Carcinoma and Correlation with the Expression of Vascular Endothelial Growth Factor].

Expression of MDM2 protein in epithelial ovarian carcinoma tissue and its clinical significance

Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis

CT findings of epithelial origin ovarian carcinoma

Expression and Clinical Significance of EGFR and Ki67 in Epithelialovarian Cancer

Expressions of P73 Protein,p21~(waf1/cip1) Protein and PCNA Protein in Epithelial Ovarian Cancer and Their Correlation

Expression of EGFR and KRAS in Patients with Epithelial Ovarian Cancer and Its Clinical Significance

Expressions of MDR1, Survivin Gene and Topoisomerase Ⅱβ in Ovarian Epithelial Carcinoma Tissues and Their Clinical Significances

Magnetic Resonance Imaging in Categorization of Ovarian Epithelial Cancer and Survival Analysis with Focus on Apparent Diffusion Coefficient Value: Correlation with Ki-67 Expression and Serum Cancer Antigen-125 Level

THE EXPRESSION OF MKP-1 AND p-ERK; IN PRIMARY OVARIAN EPITHELIAL TUMOR TISSUES

Expressions and Clinical Significances of EGFR and C-erbB-2 in Ovarian Serous Cystadenocarcinoma

[The Expression of MKP-1 and P-Erk(1/2) in Primary Ovarian Epithelial Tumor Tissues].

Expression of Proliferation Cell Nuclear Antigen Ki-67 in Ectopic Endometrium and Eutopic Endometrium

Expressions of E-cadherin and β-catenin in human primary epithelial ovarian carcinomas and their clinical significance

Expression of p73, PTEN and Ki-67 Proteins in Endometrioid Adenocarcinoma and Their Significance